Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Sotos Syndrome is primarily caused by mutations or deletions in the NSD1 gene, which plays a critical role in normal physical and intellectual development. In the vast majority of cases, these genetic changes occur sporadically (de novo) and are not inherited from parents. What is the primary genetic cause of Sotos Syndrome? The primary cause of Sotos Syndrome—often referred to as cerebral gigantism—is a disruption in the NSD1 gene located on chromosome 5 (specifically at 5q35).
TL;DR: Sotos Syndrome is primarily caused by mutations or deletions in the NSD1 gene, which plays a critical role in normal physical and intellectual development. In the vast majority of cases, these genetic changes occur sporadically (de novo) and are not inherited from parents.
The primary cause of Sotos Syndrome—often referred to as cerebral gigantism—is a disruption in the NSD1 gene located on chromosome 5 (specifically at 5q35). The NSD1 gene provides instructions for making a protein that acts as a histone methyltransferase. Think of this protein like a master volume control for the genome; it helps regulate the activity of other genes by "tagging" DNA to turn specific genes on or off during critical periods of human growth. When Sotos Syndrome occurs, the NSD1 gene is either missing, broken, or mutated, leading to the characteristic overgrowth and developmental delays associated with the condition.
Most individuals diagnosed with Sotos Syndrome do not have a family history of the condition. In approximately 95% of cases, the genetic mutation happens spontaneously at the time of conception, a process known as a de novo mutation. This means the mutation is not inherited from either parent. While Sotos Syndrome can be inherited in an autosomal dominant pattern, this is rare, occurring in only about 5% of cases where an affected parent passes the mutation to their child. Because the causes are almost exclusively genetic, there are no known environmental, infectious, or metabolic triggers that can cause a child to develop the condition.
The clinical manifestations of Sotos Syndrome are a direct result of the NSD1 protein's inability to properly regulate growth-related genes. Because the "volume control" for growth is malfunctioning, the body experiences accelerated physical growth in childhood, particularly in the head circumference and height. Current research is actively investigating the specific downstream pathways affected by NSD1, but we know the condition impacts several areas of development:
While the link between NSD1 and Sotos Syndrome is well-established, researchers are still working to understand why the clinical severity varies so greatly between individuals, even those with similar genetic deletions. Scientists are studying how NSD1 interacts with other genes to influence cognitive outcomes and long-term health. At DiseaseMaps.org, we have 98 people with Sotos Syndrome who have shared their experiences, providing a valuable community dataset that helps researchers better understand the full spectrum of the condition beyond the clinical textbook definition.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always consult with your healthcare provider regarding any medical condition.